Media & Blog

June 5, 2023 M Bio Technology was selected by JETRO to exhibit at the Japan Pavilion of the 2023 BIO International Convention, the...

May 22, 2023 Payment for stock investment type crowdfunding "FUNDINNO" has been completed. We raised 24,660,000 yen from 101 investors.

May 17, 2023 Certified as a venture company from Chiba University, M Bio Technology was listed as a venture company affiliated with Chiba...

March 28, 2023 M Bio Technology have launched a campaign of "FUNDINNO", stock investment type crowdfunding. About campaign of "FUNDINNO",...

April 18, 2023 M Bio Technology will hold an online business briefing on FUNDINNO for investors as follows. ・April 19, 2023 (Wednesday)...

March 27, 2023 Kazuhiro Matsuda, Director of the Mycoplasma Infectious Diseases Research Center, took the podium at the event "10th...

3-12 February, 2023 M Bio Techonology was selected for the "X-HUB Tokyo, London Course" operated by the Tokyo Metropolitan Government and...

February 1, 2022 Kazuhiro Matsuda, CEO at M Bio Technology and Director of the Mycoplasma Infectious Diseases Research Center, talked on...

At the Extraordinary General Meeting of Shareholders held on December 23, 2022, a decision was made to increase capital by 18 million yen.

August 26, 2022 We have been selected for JETRO's exhibition support, and have decided to exhibit at BIO-Europe Digital 2022, which will...

August 18, 2022 We have been selected as an exhibitor for "Japan Healthcare Venture Summit 2022”hosted by the Ministry of Health, Labor...

April 19, 2022 Kazuhiro Matsuda, Director of the Mycoplasma Infectious Diseases Research Center, at the event "The 4th LINK-J Member's...